Skip to content

Insider · CIK 0001266569

Patrick J Mahaffy

director

Files at MDCX (Medicus Pharma Ltd.). First filing -, latest -.

In brief

Patrick J Mahaffy files SEC Form 4 as director at MDCX (Medicus Pharma Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Patrick J Mahaffy has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 3, 2026MDCX
Medicus Pharma Ltd.
AGrant or award
Stock Option (right to buy)derivative
+50,000$0.00$050,000Jun 4, 2026
Mar 30, 2026MDCX
Medicus Pharma Ltd.
AGrant or award
Stock Option (right to buy)derivative
+25,000$0.00$025,000Apr 1, 2026
Dec 16, 2025MDCX
Medicus Pharma Ltd.
AGrant or award
Stock Option (right to buy)derivative
+25,000$0.00$025,000Dec 18, 2025

Questions about Patrick J Mahaffy

Answered from the filings on this page, as of the latest one.

Is Patrick J Mahaffy buying or selling?

Patrick J Mahaffy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Patrick J Mahaffy's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patrick J Mahaffy has 0.

Where does Patrick J Mahaffy file Form 4?

Patrick J Mahaffy has filed Form 4 at MDCX (Medicus Pharma Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Patrick J Mahaffy: insider trades and track record | InsiderTell